Noroclav Injection has a broad-spectrum of bactericidal activity against the bacteria commonly found in cattle and dogs. In vitro Noroclav Injection is active against a wide range of clinically important bacteria including Gram-positive: Staphylococci (including beta-lactamase producing strains), Streptococci, Corynebacteria, Clostridia, Bacillus anthracis, Actinomyces bovis and Gram-negative: Escherichia coli (including beta-lactamase producing strains), Salmonella spp (including beta-lactamase producing strains), Campylobacter spp, Klebsiella spp, Proteus spp, Pasteurellae spp, Fusobacterium necrophorum, Bacteroides (including beta-lactamase producing strains), Haemophilus spp, Moraxella spp and Actinobacillus lignieresi. Noroclav Injection is indicated for the treatment of diseases such as respiratory infections, soft tissue infections (e.g. jointnavel ill, abscesses etc.), metritis, mastitis in cattle and respiratory tract infections, urinary tract infections, skin and soft tissue infections (e.g. abscesses, pyoderma, anal sacculitis and gingivitis) in dogs. Noroclav Injection for Cattle and Dogs Product Information Database
